Public-Private-Partnerships in Drug Research and Development

Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.

Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update. - Project based Public private collaborations. - Collaborative Innovations in Childhood Cancer Therapies. - Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development. - The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model. - Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe. - Innovation at the Interface between Academia and Industry The BioMed X Model. - From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective. - The Legal Framework for PPP in Drug R& D.